| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 05/27/2004 | US20040101877 Regulation of human 3-ss-hydroxysteroid dehydrogenase-isomerase |
| 05/27/2004 | US20040101865 Comprises nucleotide sequences coding polypeptides associated with biosynthesis and metabolism of acetyl-CoA for preparing food, feed, cosmetics and pharmaceutical agents |
| 05/27/2004 | US20040101841 Plant promoter |
| 05/27/2004 | US20040101837 Nucleotide sequences coding for proteins involved in the biosynthesis of L-serine, an improved method for the microbial production of L-serine and a genetically modified microorganism suitable therefor |
| 05/27/2004 | US20040101832 Everninomicin biosynthetic genes |
| 05/27/2004 | US20040101580 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 05/27/2004 | US20040101562 Enzyme encapsulated in hydrophilic low melting polymer; bioavailability |
| 05/27/2004 | US20040101529 Regulation of human serine-threonine protein kinase |
| 05/27/2004 | US20040101524 Genetically engineered; treatment of mucopolysaccharidosis VI (MPS V1) or Maroteaux-Lamy syndrome; purity measured using reverse-phase high performance liquid chromatography |
| 05/27/2004 | CA2506026A1 Crystalline form of fatty acid amine hydrolase (faah) |
| 05/27/2004 | CA2505478A1 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| 05/27/2004 | CA2505118A1 Calmodulin independent activation of nitric oxide synthase by nadph analogs |
| 05/27/2004 | CA2504909A1 Xylose isomerases, nucleic acids encoding them and methods for making and using them |
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2502928A1 Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 05/27/2004 | CA2483693A1 Identification of oligoadenylate synthetase-like genes |
| 05/26/2004 | EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies |
| 05/26/2004 | EP1422293A1 Crystal structure of dipeptidyl peptidase IV |
| 05/26/2004 | EP1421990A1 Method for stabilizing active components using polyol/polymer microcapsule, and cosmetic composition containing the microcapsule |
| 05/26/2004 | EP1421539A2 Stabilized proteins with engineered disulfide bonds |
| 05/26/2004 | EP1421383A2 Method to identify modulators for human 3-alpha-hydroxysteroid dehydrogenase |
| 05/26/2004 | EP1421379A2 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 05/26/2004 | EP1421224A2 Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
| 05/26/2004 | EP1421210A2 Method of detecting protease activity in a cell |
| 05/26/2004 | EP1421197A2 Caax prenyl protease nucleic acids and polypeptides and methods of use thereof |
| 05/26/2004 | EP1421195A1 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR |
| 05/26/2004 | EP1421194A1 Regulation of human dcamkl1-like serine/threonine protein kinase |
| 05/26/2004 | EP1421193A2 Novel metabolism-associated gene products of ashbya gossypii |
| 05/26/2004 | EP1421192A1 Regulation of human ptpase-like protein |
| 05/26/2004 | EP1421186A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/26/2004 | EP1421176A2 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 05/26/2004 | EP1421175A2 Polymer stabilized proteinases |
| 05/26/2004 | EP1421112A1 Novel serine protease |
| 05/26/2004 | EP1420820A2 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
| 05/26/2004 | EP1420813A1 Pregnancy-related enzyme activity |
| 05/26/2004 | EP1420748A2 Peg-modified uricase |
| 05/26/2004 | EP1420631A1 Plant-derived resistance gene |
| 05/26/2004 | EP1420629A2 Wheat plants having increased resistance to imidazolinone herbicides |
| 05/26/2004 | EP1349952A4 Infection resistant plants and methods for their generation |
| 05/26/2004 | EP1011311A4 Controlled germination using inducible phytate gene |
| 05/26/2004 | EP0894129B1 Short external guide sequences |
| 05/26/2004 | EP0812331B1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
| 05/26/2004 | EP0805851B1 Binary bac vector |
| 05/26/2004 | CN1500143A Purified lactase |
| 05/26/2004 | CN1500142A High level cytokine prodn. with enhanced cell viability |
| 05/26/2004 | CN1499976A Caloporoside derivatives, methods for prodn. thereof and their use |
| 05/26/2004 | CN1498965A Method for preparing elspar modilfied by carbowax |
| 05/26/2004 | CN1498962A 'Tabin' aspergillus capable of producing pectase in high yield, and application in production of solid-state fermentation |
| 05/26/2004 | CN1151262C Method for expression of foreign genes and vectors therefor |
| 05/26/2004 | CN1151259C Human UMP_CMP kinase and its coding sequence, preparing process |
| 05/26/2004 | CN1151254C Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases |
| 05/26/2004 | CN1151253C Mycose base hydrolase and its preparation and use |
| 05/26/2004 | CN1151252C Method for producing microbiological transglutaminase |
| 05/26/2004 | CN1151251C New human-phosphoguanosine reductase, its coding sequence and application |
| 05/26/2004 | CN1151247C One step process for combined desizing and 'stone-washing' of dyed denim |
| 05/25/2004 | US6740793 Transgenic animal having a disrupted PDE7A gene and uses thereof |
| 05/25/2004 | US6740746 Nucleotide sequences coding polypeptide for use in the treatment and detection of of cancer, coronary or cerebrovascular, hypertensive, diabetic, arthritic and vision defects |
| 05/25/2004 | US6740742 Nucleotide sequences encoding the dapC gene and process for the production of L-lysine |
| 05/25/2004 | US6740737 Cardiovascular system associated protein kinase 2 (CSAPK-2) antibodies |
| 05/25/2004 | US6740516 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 05/25/2004 | US6740514 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumor, aberrant angiogenesis, cardiovascular, arthritis, nephritis, nervous system, vision, mouth, lung, skin, ulcer and gastrointestinal disorders |
| 05/25/2004 | US6740513 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/25/2004 | US6740512 Eukaryotic neutral sphingomyelinase (nsmase); used in drugs and in diagnosis |
| 05/25/2004 | US6740509 Method for the production of mucin-type glycopeptide |
| 05/25/2004 | US6740507 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 05/25/2004 | US6740506 End selection in directed evolution |
| 05/25/2004 | US6740498 Methods for the identification of inhibitors of histidinol-phosphate as antibiotics |
| 05/25/2004 | CA2260795C Synthetic protein folding catalysis |
| 05/21/2004 | WO2004042361A2 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 05/21/2004 | WO2004042352A2 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 05/21/2004 | WO2004042348A2 Methods for the identification of inhibitors of chitin synthase 2, s-adenosylmethionine decarboxylase, putrescine aminopropyltransferase, and methylenetetrahydrofolate reductase as antibiotics |
| 05/21/2004 | WO2004042077A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
| 05/21/2004 | WO2004042076A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) |
| 05/21/2004 | WO2004042075A2 Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use |
| 05/21/2004 | WO2004042068A2 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 05/21/2004 | WO2004042065A1 Method for obtaining the endopolygalacturonase enzyme by cultivating recombinant microbial strains overexpressing gene epg2 of kluyveromyces marxianus. |
| 05/21/2004 | WO2004042064A2 Disorders of lipid metabolism |
| 05/21/2004 | WO2004042055A1 Method of detecting bone paget’s disease |
| 05/21/2004 | WO2004042053A2 Method of preparing cross-linked enzyme particles |
| 05/21/2004 | WO2004042051A1 Method and system for creating a library of crosslinked enzyme aggregates |
| 05/21/2004 | WO2004042050A2 Improved crosslinked enzyme aggregates |
| 05/21/2004 | WO2004042049A1 Method of degrading hardly degradable protein |
| 05/21/2004 | WO2004042048A1 Modified nucleotide sequence encoding c. albicans kar3 kinesin protein |
| 05/21/2004 | WO2004042045A2 Crystal structures of bacterial thymidylate kinases |
| 05/21/2004 | WO2004042044A2 Crystal structures of bacterial guanylate kinases |
| 05/21/2004 | WO2004042043A2 Crystal structures of bacterial ribulose-phosphate 3-epimerases |
| 05/21/2004 | WO2004042022A2 Kinases and phosphatases |
| 05/21/2004 | WO2004042014A2 Mono- and diacylglycerol acyltransferases and methods of use thereof |
| 05/21/2004 | WO2004042011A2 Promotion of peroxisomal catalase function in cells |
| 05/21/2004 | WO2004042010A2 Modified luciferase nucleic acids and methods of use |
| 05/21/2004 | WO2004042008A2 Modified nucleotide sequence encoding c. albicans khc kinesin protein |
| 05/21/2004 | WO2004042006A2 Amylases, nucleic acids encoding them and methods for making and using them |
| 05/21/2004 | WO2004041979A2 Subtilase variants |
| 05/21/2004 | WO2004041856A2 Crystal structures of bacterial inorganic pyrophosphatases |
| 05/21/2004 | WO2004041115A2 Novel human elastases and stress urinary incontinence |
| 05/21/2004 | WO2004029091A3 FVII OR FVIIa VARIANTS HAVING INCREASED CLOTTING ACTIVITY |
| 05/21/2004 | WO2004027020A9 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004015097A8 Composition for stabilisation of lysozyme |
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |